From the Firepit to the Fast Lane: Biotech Breakthroughs, Billion-Dollar Builds, and the AI Infrastructure Arms Race

September 17, 2025

DENVER, Colo., Sep 17, 2025 (247marketnews.com)- Let’s break down the top movers shaping today’s narrative:

Gorilla Technology Group (NASDAQ:GRRR) signed a $1.4B, three-year contract with Singapore’s Freyr to lead the buildout of AI-powered data centers across Indonesia, Malaysia, and Thailand. The initial $300M Phase One kicks off in Q4 2025, positioning Gorilla as the infrastructure lead for sovereign, high-performance AI services in the region.

CEO Jay Chandan emphasized that they’re deploying at scale. With the Southeast Asia data center market expected to reach $15B, this deal positions GRRR as a leader in localized AI infrastructure.

If you’re tired of cold IPOs, VENU (NYSE:VENU) is turning up the heat, literally. The company, known for its luxury outdoor amphitheaters, has leveraged its initial $55M raise into $1.3B in new construction. Now, it’s adding $45M more to fund its Sunset McKinney and Sunset Broken Arrow projects, including the jaw-dropping Luxe FireSuites, VIP concert boxes with private fire pits and premium perks.

CEO J.W. Roth doubled down with a personal $5M+ investment, aiming to scale his Luxe FireSuite holdings to $20M within a year. With management estimating $200M in FireSuite sales for 2025, VENU is building a brand. As the weather cools, this small-cap is heating up with strong insider conviction and asset leverage that’s hard to ignore.

Vyome Holdings (NASDAQ:HIND) surged in early trading after presenting compelling preclinical data for VT-1908, its topical mycophenolate formulation for uveitis, a leading cause of blindness. Vyome’s drug showed significant efficacy (P<0.001) in reducing inflammation in preclinical models, with results comparable to steroids—without the risk of steroid-induced complications like cataracts and glaucoma.

Vyome’s Co-Founder, Dr. Shiladitya Sengupta, called the findings “exciting,” citing the potential to “replace steroids in the eye.” With a $3B addressable market for uveitis alone, and a $20B broader opportunity in ocular inflammation, Vyome’s VT-1908 is on track to initiate Phase 1/2 trials by late 2026. Investors are watching closely, as the company positions itself as a disruptor in chronic immune-inflammation.

Shares of Presidio Property Trust (NASDAQ:SQFT) are on a momentum tear, soaring 47.5% premarket after an 8% gain Tuesday. With speculative capital flooding into small-cap real estate and breakout stocks, SQFT is emerging as a volatility-fueled momentum play.

Caliber (NASDAQ:CWD) announced a $15.9M perpetual preferred equity raise, convertible at a lofty $250 per share, alongside activating an ATM program for up to $10.3M. Proceeds will accelerate its Digital Asset Treasury (DAT) strategy focused on Chainlink (LINK) accumulation. CEO Chris Loeffler said the capital “strengthens Caliber’s balance sheet” and validates investor confidence in the company’s hybrid infrastructure + crypto roadmap.

Caliber is the first Nasdaq-listed company to publicly anchor its treasury strategy in LINK, offering shareholders exposure to the leading decentralized oracle network, without having to hold crypto directly.

Waymo and Lyft (NASDAQ:LYFT) announced plans to deploy fully autonomous ride-hailing services in Nashville starting in 2026. Lyft’s Flexdrive unit will manage the fleet, while Waymo brings its AV tech. The dual-platform approach will allow riders to hail AVs through both the Waymo and Lyft apps.

CEO David Risher said the partnership brings together “best-in-class autonomous vehicles with best-in-class customer experience.” With fleet utilization and uptime being major bottlenecks in AV scaling, Lyft’s move into infrastructure signals a broader pivot into hybrid mobility as a service.

 Other Headlines to Watch:

  • NIO Inc. (NYSE:NIO) closed a $1.16B equity raise, with proceeds earmarked for R&D, battery swapping, and expansion across EV platforms.
  • Pebblebrook Hotel Trust (NYSE:PEB) priced $350M in convertible notes, primarily to refinance 2026 obligations, extending duration into 2030.
  • Keurig Dr Pepper (NASDAQ:KDP) declared its regular $0.23/share dividend, payable October 10 to shareholders of record on September 26.

Please click here to read Cenorium’s full Venu analyst report on 247marketnews.com.

For the full 24/7 Market News VENU report and in-depth insights, visit: Read 24/7 Market News VENU Report/

Contact sales@247marketnews.com for Analyst Report coverage and other investor/public relations services.

24/7 MARKET NEWS, INC (247) Disclaimer and Disclosure
PAID EDITORIAL DISCLOSURE: 247MarketNews.com has been compensated $2,500 per week by MicroCap Strategies for ongoing press and editorial coverage of VENU. This is a paid editorial communication intended for informational purposes only. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. This press release may include technical analysis for informational purposes only and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please go to https://247marketnews.com/venu-disclosure/ for additional 247marketnews.com VENU disclosure information.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (GRRR, VENU, HIND, SQFT, CWD, LYFT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.